Stay updated on Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRemoval of the 403 error page fragment, including the HTML header and Home link, indicating that the error page artifacts were deleted and the page now presents standard site content.SummaryDifference0.5%

- Check21 days agoChange DetectedThe page now shows a 403 Forbidden error in place of the study record details, with a basic header/footer visible, indicating access restrictions to the resource.SummaryDifference17%

- Check43 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the previous revision v3.6.5, indicating a deployment update.SummaryDifference0.1%

- Check49 days agoChange DetectedA new entry under the study identifiers notes a 2019 U.S. NIH grant/contract. This addition records the funding source associated with the study as part of its identifiers.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a backend/software update. The change does not alter the study details or page content.SummaryDifference0.1%

Stay in the know with updates to Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.